Picture of CellaVision AB logo

CEVI — CellaVision AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: Cellavision AB Q2 Organic Growth Was 15%.

CellaVision AB  CEVI.ST :
    * Q2 ORGANIC GROWTH WAS 15%.
    * APRIL 1-JUNE 30, 2018  NET SALES INCREASED BY 17% TO SEK
91.9
MILLION (78.7).
    * Q2 OPERATING PROFIT WAS SEK 31.6 MILLION (24.6)
    * "Q2 OF 2018 IS CELLAVISION'S SECOND BEST QUARTER EVER"
    * AMERICAS REPORTED STRONG GROWTH IN QUARTER

Source text for Eikon:  ID:nGNE972Hk9 
Further company coverage:  CEVI.ST

Recent news on CellaVision AB

See all news